SE9601817D0 - Novel glycolipid complexex and their uses - Google Patents

Novel glycolipid complexex and their uses

Info

Publication number
SE9601817D0
SE9601817D0 SE9601817A SE9601817A SE9601817D0 SE 9601817 D0 SE9601817 D0 SE 9601817D0 SE 9601817 A SE9601817 A SE 9601817A SE 9601817 A SE9601817 A SE 9601817A SE 9601817 D0 SE9601817 D0 SE 9601817D0
Authority
SE
Sweden
Prior art keywords
glycolipid
complexex
complex
diagnostic methods
novel glycolipid
Prior art date
Application number
SE9601817A
Other languages
English (en)
Swedish (sv)
Inventor
Pam Fredman
Karsten Buschard
Anders Jan-Eric Maansson
Original Assignee
Karsten Buschard
Anders Jan Eric Maansson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karsten Buschard, Anders Jan Eric Maansson filed Critical Karsten Buschard
Priority to SE9601817A priority Critical patent/SE9601817D0/xx
Publication of SE9601817D0 publication Critical patent/SE9601817D0/xx
Priority to AT97923373T priority patent/ATE222775T1/de
Priority to CA002253883A priority patent/CA2253883A1/en
Priority to ES97923373T priority patent/ES2183177T3/es
Priority to JP09540790A priority patent/JP2000513332A/ja
Priority to AU29188/97A priority patent/AU728141B2/en
Priority to DE69715014T priority patent/DE69715014T2/de
Priority to PCT/SE1997/000769 priority patent/WO1997042974A1/en
Priority to US09/180,492 priority patent/US6352831B1/en
Priority to PT97923373T priority patent/PT928201E/pt
Priority to DK97923373T priority patent/DK0928201T3/da
Priority to EP97923373A priority patent/EP0928201B1/en
Priority to HK00100179A priority patent/HK1021321A1/xx
Priority to US09/882,501 priority patent/US20020034769A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SE9601817A 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses SE9601817D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses
EP97923373A EP0928201B1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses
DE69715014T DE69715014T2 (de) 1996-05-13 1997-05-10 Glycolipid-komplexe und ihre anwendung.
CA002253883A CA2253883A1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses
ES97923373T ES2183177T3 (es) 1996-05-13 1997-05-10 Nuevos complejos de glicolipidos y su utilizacion.
JP09540790A JP2000513332A (ja) 1996-05-13 1997-05-10 新規糖脂質複合体およびそれらの使用
AU29188/97A AU728141B2 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses
AT97923373T ATE222775T1 (de) 1996-05-13 1997-05-10 Glycolipid-komplexe und ihre anwendung.
PCT/SE1997/000769 WO1997042974A1 (en) 1996-05-13 1997-05-10 Novel glycolipid complexes and their uses
US09/180,492 US6352831B1 (en) 1996-05-13 1997-05-10 Glycolipid complexes and their uses
PT97923373T PT928201E (pt) 1996-05-13 1997-05-10 Novos complexos glicolipidicos e suas utilizacoes
DK97923373T DK0928201T3 (da) 1996-05-13 1997-05-10 Nye Glycolipidkomplekser og deres anvendelse
HK00100179A HK1021321A1 (en) 1996-05-13 2000-01-11 Novel glycolipid complexes and their uses
US09/882,501 US20020034769A1 (en) 1996-05-13 2001-06-15 Novel glycolipid complexes and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses

Publications (1)

Publication Number Publication Date
SE9601817D0 true SE9601817D0 (sv) 1996-05-13

Family

ID=20402548

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601817A SE9601817D0 (sv) 1996-05-13 1996-05-13 Novel glycolipid complexex and their uses

Country Status (13)

Country Link
US (2) US6352831B1 (da)
EP (1) EP0928201B1 (da)
JP (1) JP2000513332A (da)
AT (1) ATE222775T1 (da)
AU (1) AU728141B2 (da)
CA (1) CA2253883A1 (da)
DE (1) DE69715014T2 (da)
DK (1) DK0928201T3 (da)
ES (1) ES2183177T3 (da)
HK (1) HK1021321A1 (da)
PT (1) PT928201E (da)
SE (1) SE9601817D0 (da)
WO (1) WO1997042974A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049477A1 (en) * 1997-12-30 2000-11-08 A+ Science Invest AB Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
SE0000258D0 (sv) * 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US6824999B1 (en) * 2000-05-05 2004-11-30 Athena Diagnostics, Inc. Detection of antibodies to gangliosides using solid-phase reactants coated with carbonyl groups
US6599756B1 (en) * 2000-07-27 2003-07-29 Athena Diagnostics, Inc. Detection of antibodies to glycosphingolipids using solid-phase reactants coated with carbonyl groups
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
EP1940418B1 (en) * 2005-09-29 2011-01-19 Torrey Pines Institute For Molecular Studies Sulfatides for treatment of autoimmune disorders
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS628055A (ja) 1985-07-05 1987-01-16 Shinotesuto Kenkyusho:Kk 酵素免疫測定方法
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
AU5743994A (en) * 1992-12-10 1994-07-04 Enzon, Inc. Glycolipid enzyme-polymer conjugates

Also Published As

Publication number Publication date
DK0928201T3 (da) 2002-12-23
EP0928201B1 (en) 2002-08-28
PT928201E (pt) 2003-01-31
HK1021321A1 (en) 2000-06-09
US6352831B1 (en) 2002-03-05
ES2183177T3 (es) 2003-03-16
AU728141B2 (en) 2001-01-04
EP0928201A1 (en) 1999-07-14
WO1997042974A1 (en) 1997-11-20
JP2000513332A (ja) 2000-10-10
ATE222775T1 (de) 2002-09-15
US20020034769A1 (en) 2002-03-21
AU2918897A (en) 1997-12-05
DE69715014D1 (de) 2002-10-02
CA2253883A1 (en) 1997-11-20
DE69715014T2 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
GB1498081A (en) Covalently bound biological substances to plastic materials and use in radioassay
JPS5763454A (en) Immuno assay method and assay apparatus
FI932912A (fi) Testmetod och reagensfoerpackning avsedd foer den
SE9601817D0 (sv) Novel glycolipid complexex and their uses
ES2009312A6 (es) Dispositivo y metodo pra inmunoensayo de analitos multiples.
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
AU564575B2 (en) Polyvalent endotoxin specific antibodies
ES468934A1 (es) Una unidad de ensayo para realizar un metodo de inmunoensayoque emplea enzimas.
CA2089395A1 (en) Monoclonal antibodies for detecting water treatment polymers
ATE90790T1 (de) Verfahren zur herstellung einer festphasenmatrix.
FR2502786B1 (fr) Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
EP0368273A3 (en) New method of assay for antigen
SE7901166L (sv) Reagens for anvendning vid immunoanalys
ATE316244T1 (de) Vollblut-immunoassay
CA2075695A1 (en) Monoclonal antibodies to sulfonated polymers
ES516244A0 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
FI861715A (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
DK398086A (da) Fremgangsmaade til foroegelse af oploeseligheden af immunokonjugatpraeparationer eller ukonjugeret immunoglobulin samt fremgangsmaade til nedsaettelse af intakte toksinkonjugaters toksicitet
EP0407605A4 (en) Reagent for detecting antibody corresponding to acid-fast bacterium antigen and application thereof
FI913530A0 (fi) Exkretoriska/sekretoriska bandmask -(cysticercus cellulosae)-antigener foer anvaendning i immunodiagnosis och vaccinationspreparat.
JPS52154520A (en) Modified antibody and its preparation
KR860008779A (ko) 항체 형성 화합물의 제조방법
JPS5386014A (en) Quantitative analysis of antigen and antibody
ZA98587B (en) A novel antigen from P. aeruginosa, and its use in medicine.